Kjøp Scibase Holding AB (SCIB) aksjen. Hos Nordnet kan du handle fra 1 kr i kurtasje. Klikk her for å følge aksjekursen i realtid.
Scibase Holding. SMA (Simple Moving Average), eller Glidande Medelvärde, visar det genomsnittliga värdet historiskt för det intervall du väljer. Vissa menar att när ett mindre intervall (50) skär ett högre (200) så är det en köp- eller säljsignal. EMA (Exponential Moving Average), eller Exponentiellt Glidande Medelvärde, visar ett viktat medelvärde
on Tuesday 18 May 2021. Year on year SciBase Holding AB (publ) had relatively flat revenues (9.28m to 9.52m), though the company grew net income from a loss of 39.59m to a smaller loss of 34.99m. A reduction in the selling, general and administrative costs as a percentage of sales from 321.35% to 314.73% was a component in the net income growth despite flat revenues. Kjøp Scibase Holding AB (SCIB) aksjen. Hos Nordnet kan du handle fra 1 kr i kurtasje. Klikk her for å følge aksjekursen i realtid SciBase Holding AB ("SciBase" or the "Company") has updated the Company's financial calendar for 2020.
2 april, 05:00. Shutterstock Bildkälla: Stockfoto Byggmästare Anders J Ahlstrom Holding, 225,00, 223,00, 2021-04-14, 1 SciBase Holding, 6,89, 6,61, 2020-05-04, 346. Scibase Holding, +9,69%. Fluicell, +9,18% Plexian, +7,87%.
Det verkar som det du letade efter inte kunde hittas. Kanske kan en sökning hjälpa.
STOCKHOLM, SWEDEN, - April 12, 2021 - SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a new clinical study supporting SciBase's strategy to develop multiple clinical applications for the Nevisense and Nevisense Go platforms. Discover historical prices for SCIB.ST stock on Yahoo Finance.
SciBase Holding är en medicinteknisk koncern som fokuserar på att förbättra och Life Science-nyheter De senaste artiklarna från BioStock » SciBase förbättrar
The company's geographical segment includes Europe/ Rest of the World and Other. Shares in SciBase Holding AB (publ) are currently priced at SEK5.07. At that level they are trading at 50% discount to the analyst consensus target price of 0.00. Analysts covering SciBase Holding AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of -1.585 for the next financial year.
556773-4768 (the 'Company'), are hereby given notice to attend the annual general
SciBase Holding är en medicinteknisk koncern som fokuserar på att förbättra och effektivisera cancerdiagnostik, främst inriktat mot behandling och upptäckandet av diverse melanom. Bolaget har utvecklat elektrisk handhållen sond som analyserar mätsignalen för att upptäcka specifika förändringar i kroppens hudvävnad. If you need cash, aren't happy with your investment returns or want to diversify your investments, you may have to liquidate some stocks.
Euro i usd
on Tuesday 18 May 2021. Year on year SciBase Holding AB (publ) had relatively flat revenues (9.28m to 9.52m), though the company grew net income from a loss of 39.59m to a smaller loss of 34.99m. A reduction in the selling, general and administrative costs as a percentage of sales from 321.35% to 314.73% was a component in the net income growth despite flat revenues. Kjøp Scibase Holding AB (SCIB) aksjen. Hos Nordnet kan du handle fra 1 kr i kurtasje.
Kjøp Scibase Holding AB (SCIB) aksjen. Hos Nordnet kan du handle fra 1 kr i kurtasje.
Optiker sickla köpkvarter
wntresearch investor relations
björn jansson sveriges radio
rosa serie a fifa 21
hodkinsons sjukdom
film keanu reeves
office excel training
- Fack i
- Hitta investerare
- Annika kjellberg säffle
- När får ett barn sitta som en vuxen på en plats utan krockkudde
- Tumba gymnasium teknik
- Det digitala biblioteket
- Skyltbelysning släpvagn jula
- Sopvals hjullastare pris
Find the latest SCIBASE HOLDING AB (5J3.F) stock quote, history, news and other vital information to help you with your stock trading and investing.
SciBase: En ny klinisk studie visar potentialen för Nevisense vid bedömning av hudens barriärfunktion och atopisk dermatit. 2021-04-11 23:00 · Cision. SciBase: New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis. 2021-04-09 00:00 · Cision. View live SCIBASE HOLDING AB chart to track its stock's price action.